Division of Gynecology and Gynecological Oncology
Profile
- Endometriosis studies: Pathophysiology, endometriosis-associated pain, development of a non-invasive diagnostic tool (study ADOmiARN), recurrence and treatment non-response, impact on fertility and pregnancy, development of Apps (study Nalu)
- Pathophysiology of gynaecologic cancers
- Quality of life before and after urogynaecologic interventions (study Lavic)
- Physiologic and pathophysiologic changes of the pelvic floor during exercises
- Transgender studies
External Partners
Scailyte; Roche Diagnostics International Ltd; Center for Gender Variance, Univ. of Basel; Berner Fachhochschule, Bern; Dell Medical School, Univ. of Texas, Austin; Croydon Univ. Hospital, London; Dept. of Obstetrics & Gynaecology, Inst. for Molecular Biosciences, Queensland; Clinical Pathology & Cytology, Karolinska Univ. Hospital, Stockholm; Dept. of Urogynaecology, Princess-N-Hospital, Southampton; Dept. of Obstetrics & Gynecology, Ospedale Santa Chiara di, Trento; Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
Grants
- Foundation for clinical-experimental cancer research
- Bern University Research Foundation
- Urethral vascularisation and urodynamic measurement for stress incontinence
- Further funding source: Roche Diagnostics International Ltd
Division of Obstetrics and Feto-Maternal Medicine
Profile
- Stem cells, exosomes, non-coding RNA for prevention and treatment of perinatal brain damage and neuroregeneration in preterm birth
- Astroglial function as target for diagnosis and treatment of perinatal brain damage in preterm birth and intrauterine growth restriction
- Clinical trials in novel procoagulant treatments of postpartum haemorrhage, preterm birth and preeclampsia
- Clinical trial of wearable continuous glucose monitoring in gestational diabetes
- Clinical trial of perinatal microbiota and neonatal and child development
- Transmembrane transporter and biomarker in preeclampsia and preterm birth
- Molecular signature of circulating free DNA in maternal blood in adverse pregnancy outcome
- Development of novel wearable devices for AI-based diagnosis of maternal disorders and fetal condition in pregnancy
- Sars-CoV-2 infection in pregnancy: placental disease
External Partners
Obstetrics and Feto-maternal Medicine departments Basel, Zurich, and Lausanne, abroad (USA, Germany, Finland, The Netherlands), ETH Zurich, CSEM Neuchatel and Bern, several industry partners
Grants
- EU Horizon / Innosuisse Grant: Remote wearable non-invasive monitoring in pregnant women
- EU Grant COST: International network for translating research on perinatal derivatives
- SNSF Ambizione Grant: Astroglial function in perinatal brain damage
- SNSF Research Grant: Role of Klotho in fetal growth restriction and premature aging (joint grant with Prof Huynh-Do, Nephrology, University of Bern)
- SNSF Research Grant: The Ethics of prenatal genomic testing in Switzerland: Understanding stakeholders views (joint with Prof Vayena, ETH Zurich)
- Bangerter Foundation Grant: Mesenchymal stem cells-derived exosomes as a neuroregenerative therapy
- Konol Trust Grant: Clinical research in perinatal disoders
- Focus Grant Medical Faculty: FemTech Digital Twin approach to improve Women’s Health
- Focus Grant Medical Faculty: Harnessing extracellular vesicles for cell-based therapies
- Medical Faculty PRT Grant (protected research time): Gestational diabetes
- Medical Faculty PRT Grant (protected research time): Astroglial function in perinatal brain damage
- Grant SGGG / Bayer: Astroglial function in perinatal brain damage
